Premji, Z.; Umeh, R.E.; Owusu-Agyei, S.; Esamai, F.; Ezedinachi, E.U.; Oguche, S; Borrmann, S.; Sowunmi, A.; Duparc, S.; Kirby, P.L.; Pamba, A.; Kellam, L.; Guiguemdé, R.; Greenwood, B.; Ward, S.A.; Winstanley, P.A.
(PLoS One, 2009)
BACKGROUND: Chlorproguanil-dapsone-artesunate (CDA) was developed as an
affordable, simple, fixed-dose artemisinin-based combination therapy for use in
Africa. This trial was a randomized parallel-group, double-blind, ...